SAN DIEGO—In 10 years, will colonoscopy still be the standard screening modality for colorectal cancer? Despite the kerfuffle over the Northern-European Initiative on Colorectal Cancer (NordICC) trial results, it probably will, but it will undoubtedly be accompanied by new noninvasive options that will improve screening adherence, according to Aasma Shaukat, MD, MPH, the Robert M. and Mary H. Glickman Professor of Medicine and director of GI Outcomes Research at the NYU Grossman School of
NOVEMBER 23, 2022